Skip to main content
UniHealth

Doctor search

Asghar Askari, MD

Urology · San Pedro

NPI 1922116698

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1
Since medical school
54 years
Graduated 1972

Offices

1 location

Looking this up.

Hospitals listed: Providence Little Company of Mary Med Ctr Torrance · Providence Little Co of Mary Med Ctr San Pedro. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Askari’s office at (310) 519-9100 to ask if they take your plan before you enroll.

California Medical Board record

Licence A35822 · Current

Licensed to practise in California · since 1980 · expires 2028-01-31 · National University of Iran Faculty of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Surgery centers they own

  • Pacific Coast Surgical CenterAmbulatory Surgery Center · Torrance, CAOwner · accredited by JC
    Denied Accreditation1 inspection, 1 with deficiencies · last 2014-03-17: Requirements Met
  • Pacific Coast Surgical Center, LPAmbulatory Surgery Center · Torrance, CA2% owner since 2008 · accredited by AAAHC
    Accreditation Renewed5 inspections, 4 with deficiencies · last 2024-09-10: Requirements Met

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Surgery - Surgery
  • American Board of Urology - Female Pelvic Medicine and Reconstructive Surgery
  • American Board of Urology - Pediatric Urology
  • American Board of Urology - Urology

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Providence Little Co of Mary Med Ctr San PedroSan Pedro, CAAcute Care Hospital · Voluntary non-profit - Private · No emergency departmentPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 71% would definitely recommend it
    Overall rating: 4 of 5 starsNo measure marked better or worse than the national rate
  • Providence Little Company of Mary Med Ctr TorranceTorrance, CAAcute Care Hospital · Voluntary non-profit - Church · No emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 70% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.472, Oct 2024 – Sep 2025
See every measure and the patient survey for Providence Little Co of Mary Med Ctr San Pedro

Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 2 the same, 0 worse of 3 measures. Readmissions: 0 better, 6 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Providence Little Co of Mary Med Ctr San Pedro
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.01 (0 to 2.08) · 260 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.89 (0.45 to 1.33)No differentJul 2022 – Jun 2024
Death rate for COPD patientsComplications and deaths9.3 · 27 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.2 · 86 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths13.8 · 115 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.2 · 46 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.3 · 844 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.26 (0.03 to 0.49) · 1,991 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.26 (0.04 to 0.47) · 1,930 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.21 (0.68 to 5.75) · 195 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.66 (0 to 3.39) · 51 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.6 (0.89 to 4.31) · 181 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.82 (0 to 18.7) · 51 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.05 (0.78 to 9.31) · 47 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.75 (0.22 to 3.27) · 53 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.35 (0 to 1.36) · 1,620 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.7 · 28 casesNoneApr 2023 – Mar 2025
Clostridium Difficile (C.Diff)Infections0.687No differentOct 2024 – Sep 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits21.2 · 170 casesNoneJul 2023 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-2.2 · 103 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-5.6 · 126 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.2 · 182 casesNoneJul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits6.1 · 25 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.9 · 52 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.8 (9.3 to 17.3) · 120 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.7 to 1.5) · 56 casesNo differentJan 2024 – Dec 2024

What patients said (414 patients answered, 17% of those asked)

Patient survey stars by topic at Providence Little Co of Mary Med Ctr San Pedro
Cleanliness4
Nurse communication3
Doctor communication3
Communication about medicines3
Discharge information3
Overall hospital rating4
Quietness2
Recommend hospital4
Share of patients giving the best answer at Providence Little Co of Mary Med Ctr San Pedro
Room was "always" clean79%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained62%
Yes, staff "did" give patients this information86%
Yes, staff "did" give patients information about help after discharge86%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully77%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)75%
Staff "always" explained new medications77%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect85%
"Always" quiet at night43%
"YES", patients would definitely recommend the hospital71%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms86%
See every measure and the patient survey for Providence Little Company of Mary Med Ctr Torrance

Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 8 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Providence Little Company of Mary Med Ctr Torrance
Clostridium Difficile (C.Diff)Infections0.472BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.09 (0.11 to 2.07) · 1,022 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.9 (0.59 to 1.2)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths129.31 (75.73 to 182.88) · 65 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2 · 36 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths10.3 · 70 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11 · 141 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths8.4 · 353 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths14.2 · 361 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.5 · 495 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.4 · 3,150 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.19 (0 to 0.39) · 5,786 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.25 (0.06 to 0.45) · 5,832 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.21 (2.1 to 6.32) · 1,135 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.81 (0.22 to 3.4) · 375 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.33 (0.8 to 3.86) · 1,086 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.78 (2.28 to 15.28) · 389 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.58 (1.19 to 7.98) · 377 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths2 (0.51 to 3.49) · 247 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.3 (0 to 0.93) · 4,918 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.9 · 127 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.892No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.225No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.363No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.7 · 283 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits22 · 709 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits10.5 · 149 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits7.9 · 428 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-13.8 · 369 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.6 · 551 casesNoneJul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 130 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.7 · 59 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 168 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits11.8 (8.9 to 15.5) · 642 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.7 to 1.3) · 331 casesNo differentJan 2024 – Dec 2024

What patients said (414 patients answered, 18% of those asked)

Patient survey stars by topic at Providence Little Company of Mary Med Ctr Torrance
Cleanliness3
Nurse communication4
Doctor communication3
Communication about medicines3
Discharge information3
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Providence Little Company of Mary Med Ctr Torrance
Room was "always" clean69%
Nurses "always" communicated well78%
Doctors "always" communicated well75%
Staff "always" explained60%
Yes, staff "did" give patients this information85%
Yes, staff "did" give patients information about help after discharge86%
Doctors "always" explained things so they could understand71%
Doctors "always" listened carefully74%
Doctors "always" treated them with courtesy and respect81%
Patients who gave a rating of "9" or "10" (high)67%
Staff "always" explained new medications75%
Nurses "always" explained things so they could understand74%
Nurses "always" listened carefully76%
Nurses "always" treated them with courtesy and respect85%
"Always" quiet at night45%
"YES", patients would definitely recommend the hospital70%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms84%

Original Medicare doctor bills

$105,061

Medicare paid this office $105,061 for 388 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Short return visit (20+ min)297$46,690$73
Return visit (30+ min)60$6,661$101
New patient visit (45+ min)43$5,546$129
Diagnostic exam of bladder and urethra using an endoscope19$4,561$198
Injection of drug or substance under skin or into muscle35$2,260$12
See all 10 services
Every Original Medicare service billed
Short return visit (20+ min)297$46,690$73
Return visit (30+ min)60$6,661$101
New patient visit (45+ min)43$5,546$129
Diagnostic exam of bladder and urethra using an endoscope19$4,561$198
Injection of drug or substance under skin or into muscle35$2,260$12
Initial hospital care with moderate level of medical decision making at least 75 minutes15$2,129$142
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle18$1,370$30
Electronic assessment of bladder emptying88$1,204$10
Ultrasound measurement of bladder capacity after voiding99$1,184$9
Injection, testosterone cypionate, 1 mg32$3None

Procedures Medicare counted

Procedure volume Medicare published
Prostate resection22More than 82% of doctors who do this
Removal of the uterus1-10None

Procedures year by year

Procedures billed to Original Medicare by year
Procedure201920202021202220232024
Ultrasound measurement of bladder capacity after voiding245254335361298131
Electronic assessment of bladder emptying249236319314267117
Insertion of implant in urethra within prostate gland using an endoscope, each additional implant62138160131––
Diagnostic exam of bladder and urethra using an endoscope626468553723
Insertion of implant in urethra within prostate gland using an endoscope, 1 implant14272828––
Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies14–271412–

Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.

Who their Medicare patients are

388 Original Medicare patients in 2024. Average age 77 · Under 65 6% · 85 and older 21% · Women 21% · Also on Medicaid 25% · Health risk score 1.51. Above the middle of the specialty; the typical urology clinician is at 1.36.

Conditions among them: High blood pressure 75% · Diabetes 44% · Coronary heart disease 28% · Chronic kidney disease 28% · Cancer 21% · Atrial fibrillation 21% · Heart failure 19% · Depression 19% · COPD 14% · Stroke 10% · Dementia 8%.

The office billed $473,423, Medicare allowed $138,629 and paid $105,061; for 1,637 services of 51 kinds; $3,074 of it was for drugs given in the office and $101,987 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20243881,637771.51$473,423$105,061
20234521,904771.44$804,200$178,139
20224292,412771.31$1,110,203$243,086
20214332,184771.43$1,036,539$338,716
20204511,973761.40$674,172$231,808
20195382,281761.54$717,493$261,546
20184261,731751.43$498,858$151,858
20173721,463751.49$396,007$109,789
20163431,305751.61$347,282$103,863
20153951,416741.67$444,859$135,655
20144521,780731.60$487,251$139,043
20134811,800731.69$547,686$152,872

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 12 services

Original Medicare services billed in 2023
Short return visit (20+ min)295$51,716$71
New patient visit (45+ min)64$7,993$125
Diagnostic exam of bladder and urethra using an endoscope34$7,880$213
Return visit (30+ min)57$7,162$105
Initial hospital care with moderate level of medical decision making at least 75 minutes31$4,717$143
Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies12$3,622$302
Electronic assessment of bladder emptying152$2,871$11
Ultrasound measurement of bladder capacity after voiding167$2,637$9
Insertion of device into abdomen with pressure and urine flow rate study15$2,581$172
Biopsy of prostate gland13$2,568$198
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes26$1,943$41
Ultrasound scan of pelvic region through rectum14$1,892$118

2022: 18 services

Original Medicare services billed in 2022
Short return visit (20+ min)307$68,000$75
Insertion of implant in urethra within prostate gland using an endoscope, each additional implant11$55,041$860
Insertion of implant in urethra within prostate gland using an endoscope, 1 implant11$13,256$1,205
Diagnostic exam of bladder and urethra using an endoscope53$11,818$215
New patient visit (45+ min)75$10,565$141
Complex measurement of pressure of urine flow in bladder with voiding pressure studies42$9,978$232
Return visit (30+ min)64$7,608$106
Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies14$4,787$342
Initial hospital care with moderate level of medical decision making at least 75 minutes25$4,683$167
Insertion of device into abdomen with pressure and urine flow rate study20$3,718$186
Electronic assessment of bladder emptying169$3,351$11
Ultrasound measurement of bladder capacity after voiding182$3,243$9
Insertion of implant in urethra within prostate gland using an endoscope, 1 implant17$3,000$176
Insertion of implant in urethra within prostate gland using an endoscope, each additional implant13$2,830$42
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes38$2,111$32
Ultrasound scan of pelvic region through rectum13$1,610$124
New patient visit (30+ min)14$1,179$84
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings25$808$29

2021: 15 services

Original Medicare services billed in 2021
Insertion of implant in urethra within prostate gland using an endoscope, each additional implant28$152,739$955
Short return visit (20+ min)306$57,742$71
Insertion of implant in urethra within prostate gland using an endoscope, 1 implant28$37,018$1,322
Diagnostic exam of bladder and urethra using an endoscope59$14,335$211
Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies27$9,965$369
Exam of bladder and urethra for treatment of female urethral syndrome using an endoscope16$5,663$283
New patient visit (45+ min)39$5,422$139
Electronic assessment of bladder emptying167$3,500$11
Initial hospital care with moderate level of medical decision making at least 75 minutes20$3,426$171
New patient visit (30+ min)37$3,354$91
Return visit (30+ min)31$3,289$103
Ultrasound measurement of bladder capacity after voiding178$2,973$9
Ultrasound scan of pelvic region through rectum13$1,572$121
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes13$754$33
Urinalysis, manual test22$77$3

2020: 18 services

Original Medicare services billed in 2020
Insertion of implant in urethra within prostate gland using an endoscope, each additional implant14$70,743$943
Short return visit (20+ min)304$39,883$53
Insertion of implant in urethra within prostate gland using an endoscope, 1 implant14$17,822$1,273
Leuprolide acetate (for depot suspension), 7.5 mg16$14,219None
Diagnostic exam of bladder and urethra using an endoscope53$11,986$187
Initial hospital care with moderate level of medical decision making at least 75 minutes31$5,638$171
New patient visit (30+ min)62$5,454$88
Ultrasound scan of pelvic region through rectum28$3,885$134
Exam of bladder and urethra for treatment of female urethral syndrome using an endoscope13$3,825$273
New patient visit (45+ min)25$3,613$145
Biopsy of prostate gland15$3,380$225
Insertion of implant in urethra within prostate gland using an endoscope, each additional implant13$2,784$44
Electronic assessment of bladder emptying145$2,605$11
Insertion of implant in urethra within prostate gland using an endoscope, 1 implant13$2,315$178
Return visit (30+ min)24$2,226$82
Ultrasound measurement of bladder capacity after voiding158$2,178$9
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes19$1,119$34
Urinalysis, manual test25$90$3

2019: 20 services

Original Medicare services billed in 2019
Insertion of implant in urethra within prostate gland using an endoscope, each additional implant12$54,433$878
Short return visit (20+ min)376$51,418$55
Insertion of implant in urethra within prostate gland using an endoscope, 1 implant14$16,506$1,179
New patient visit (30+ min)194$15,576$80
Leuprolide acetate (for depot suspension), 7.5 mg21$14,259None
Diagnostic exam of bladder and urethra using an endoscope55$10,180$164
Initial hospital care with moderate level of medical decision making at least 75 minutes52$9,799$169
Shock wave crushing of kidney stones15$8,435$496
Complete laser vaporization of prostate including control of bleeding using an endoscope13$7,807$601
Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies14$4,566$326
Biopsy of prostate gland18$4,029$224
Ultrasound scan of pelvic region through rectum31$3,640$117
Exam of bladder and urethra for treatment of female urethral syndrome using an endoscope16$3,498$206
Insertion of stent in ureter using an endoscope21$2,899$132
Electronic assessment of bladder emptying164$2,732$11
Return visit (30+ min)31$2,699$84
Ultrasound measurement of bladder capacity after voiding166$2,557$10
New patient visit (45+ min)14$1,990$142
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes21$1,065$33
Urinalysis, manual test17$61$3

2018: 17 services

Original Medicare services billed in 2018
Short return visit (20+ min)275$43,340$53
Destruction of prostate tissue using microwave induced heat13$24,279$1,868
Complete laser vaporization of prostate including control of bleeding using an endoscope21$12,189$580
Initial hospital care with moderate level of medical decision making at least 75 minutes47$8,030$167
New patient visit (30+ min)87$7,611$87
Leuprolide acetate (for depot suspension), 7.5 mg12$5,466None
Shock wave crushing of kidney stones11$5,310$483
Diagnostic exam of bladder and urethra using an endoscope36$4,503$122
Return visit (30+ min)52$4,262$75
Biopsy of prostate gland11$2,610$218
Ultrasound measurement of bladder capacity after voiding133$2,602$14
Electronic assessment of bladder emptying123$2,227$13
Exam of bladder and urethra for treatment of female urethral syndrome using an endoscope11$2,171$197
New patient visit (45+ min)13$1,797$138
Ultrasound scan of pelvic region through rectum12$1,115$86
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes20$935$32
Urinalysis, manual test16$55$3

2017: 14 services

Original Medicare services billed in 2017
Short return visit (20+ min)239$36,898$53
Complete laser vaporization of prostate including control of bleeding using an endoscope22$12,653$575
Return visit (30+ min)63$5,127$78
New patient visit (30+ min)64$5,012$78
Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies13$3,623$279
Initial hospital care with moderate level of medical decision making at least 75 minutes19$3,129$165
Diagnostic exam of bladder and urethra using an endoscope24$3,087$123
Exam of bladder and urethra for treatment of female urethral syndrome using an endoscope15$2,846$178
Ultrasound measurement of bladder capacity after voiding121$2,585$16
Electronic assessment of bladder emptying108$1,861$12
Long return visit (40+ min)18$1,666$93
Insertion of device into abdomen with pressure and urine flow rate study11$1,079$98
Insertion of temporary bladder tube12$775$41
Urinalysis, manual test30$103$3

2016: 14 services

Original Medicare services billed in 2016
Short return visit (20+ min)252$33,499$53
Complete laser vaporization of prostate including control of bleeding using an endoscope21$12,308$586
New patient visit (30+ min)79$6,816$86
Diagnostic exam of bladder and urethra using an endoscope32$5,190$148
Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies16$4,759$297
Return visit (30+ min)57$3,999$66
Initial hospital care with moderate level of medical decision making at least 75 minutes21$3,702$168
Biopsy of prostate gland12$2,439$188
Ultrasound measurement of bladder capacity after voiding80$1,591$16
Insertion of device into abdomen with pressure and urine flow rate study14$1,371$98
Long return visit (40+ min)15$1,215$81
Electronic assessment of bladder emptying71$1,131$12
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes14$816$31
Urinalysis, manual test20$75$3

2015: 16 services

Original Medicare services billed in 2015
Short return visit (20+ min)253$31,624$52
Complete laser vaporization of prostate including control of bleeding using an endoscope18$10,453$581
Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies25$7,262$290
Diagnostic exam of bladder and urethra using an endoscope41$6,867$149
Return visit (30+ min)82$5,978$64
New patient visit (30+ min)52$4,242$82
Initial hospital care with moderate level of medical decision making at least 75 minutes21$3,861$168
Exam of bladder and urethra for treatment of female urethral syndrome using an endoscope15$2,538$159
Insertion of device into abdomen with pressure and urine flow rate study21$2,081$99
Insertion of stent in ureter using an endoscope11$1,731$124
Ultrasound measurement of bladder capacity after voiding75$1,534$16
Ultrasound scan of pelvic region through rectum17$1,408$78
Long return visit (40+ min)13$1,078$83
Electronic assessment of bladder emptying68$984$11
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes16$917$33
Urinalysis, manual test30$119$3

2014: 23 services

Original Medicare services billed in 2014
Short return visit (20+ min)256$28,809$52
Complete laser vaporization of prostate including control of bleeding using an endoscope24$13,938$581
Insertion of lower leg neurostimulator electrode13$9,779$104
Diagnostic exam of bladder and urethra using an endoscope54$8,933$162
Leuprolide acetate (for depot suspension), 7.5 mg11$6,831None
New patient visit (30+ min)71$5,348$75
Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies14$4,081$291
Biopsy of prostate gland18$3,371$187
Initial hospital care with moderate level of medical decision making at least 75 minutes17$3,226$170
Ultrasound measurement of bladder capacity after voiding146$3,121$15
Return visit (30+ min)45$2,990$59
Exam of bladder and urethra for treatment of female urethral syndrome using an endoscope15$2,616$174
Short return visit (20+ min)39$2,446$42
Electronic assessment of bladder emptying129$2,173$12
Ultrasound scan of pelvic region through rectum25$2,044$82
Diagnostic exam of bladder and urethra using an endoscope11$1,393$107
Insertion of device into abdomen with pressure and urine flow rate study13$1,273$98
Ultrasonic guidance for needle placement19$1,227$65
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle11$1,100$28
Long return visit (40+ min)11$882$80
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes14$819$33
Short return visit23$528$20
Urinalysis, manual test31$147$3

2013: 18 services

Original Medicare services billed in 2013
Short return visit (20+ min)261$27,614$53
Complete laser vaporization of prostate including control of bleeding using an endoscope28$15,678$560
Diagnostic exam of bladder and urethra using an endoscope59$10,978$164
New patient visit (30+ min)81$6,402$79
Initial hospital care with moderate level of medical decision making at least 75 minutes25$4,099$164
Ultrasonic guidance for needle placement20$3,348$159
Ultrasound measurement of bladder capacity after voiding147$3,344$16
Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies12$3,285$274
Biopsy of prostate gland19$3,179$167
Return visit (30+ min)42$2,800$62
Short return visit (20+ min)52$2,180$36
Exam of bladder and urethra for treatment of female urethral syndrome using an endoscope12$2,114$176
Diagnostic exam of bladder and urethra using an endoscope21$2,068$98
Electronic assessment of bladder emptying121$2,058$11
Ultrasound scan of pelvic region through rectum26$1,694$61
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes27$1,521$32
Short return visit25$525$18
Urinalysis, manual test66$285$3

Medicaid work

$1,760 in 2024

Medicaid paid $1,760 for 143 billed services this clinician did in 2024, up to 22 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Short return visit (20+ min)103$1,040
New patient visit (45+ min)40$720
Medicaid work by year
2024143222$1,760
202393117$1,023
2022128217$3,859
2021103116$1,655
201916114$300
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Short return visit (20+ min)93$1,023

2022

Largest Medicaid services in 2022
Short return visit (20+ min)116$3,122
New patient visit (45+ min)12$737

2021

Largest Medicaid services in 2021
Short return visit (20+ min)103$1,655

2019

Largest Medicaid services in 2019
Short return visit (20+ min)16$300

Drugs they prescribed that Part D paid

$559,840

Pharmacies billed $559,840 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 3% of their Part D prescriptions (76 of 2,723) in 2024. Above the middle of the specialty; the typical urology clinician is at 2%.

2,502 generic and fewer than 11 brand-name prescriptions · $559,840 in drug cost · 553 antibiotic prescriptions to 257 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Xtandi27$372,034$13,779
Gemtesa74$59,731$807
Myrbetriq88$53,112$604
Tamsulosin885$12,708$14
Testosterone46$7,688$167
See all 25 drugs
Every Part D drug this clinician prescribed
Xtandi27$372,034$13,779
Gemtesa74$59,731$807
Myrbetriq88$53,112$604
Tamsulosin885$12,708$14
Testosterone46$7,688$167
Dutasteride204$5,982$29
Methenamine Hippurate61$4,396$72
Alfuzosin Hcl Er191$4,093$21
Tadalafil16$4,086$255
Bethanechol Chloride43$2,969$69
Potassium Citrate Er34$2,431$72
Nitrofurantoin Mono-Macro100$2,380$24
Fesoterodine Fumarate Er31$1,539$50
Ciprofloxacin293$1,219$4
Solifenacin29$1,142$39
Finasteride102$955$9
Cefuroxime76$862$11
Bicalutamide24$551$23
Sulfamethoxazole-Trimethoprim46$413$9
Testosterone Cypionate11$321$29
Oxybutynin Chloride Er18$204$11
Allopurinol11$162$15
Tramadol65$96$1
Ibuprofen30$53$2
Meloxicam11$13$1

Year by year

Part D prescribing by year
20242,7235303% (76)None$559,840
20232,4404913% (63)None$506,827
20222,5764943% (65)None$279,732
20212,7795734% (104)9%$385,635
20203,5567283% (107)None$763,444
20193,4977733% (120)14%$674,838
20182,6526063% (69)None$272,399
20171,9984484% (75)14%$233,458
20161,9444295% (93)None$136,668
20151,9833972% (47)22%$151,454
20141,9544083% (49)30%$167,728
20132,0533924% (74)30%$185,049

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 26 drugs

Part D drugs prescribed in 2023
Xtandi20$301,377$15,069
Myrbetriq81$55,840$689
Gemtesa32$24,450$764
Tamsulosin801$18,353$23
Dutasteride198$14,441$73
Alfuzosin Hcl Er177$7,843$44
Bethanechol Chloride64$4,806$75
Fesoterodine Fumarate Er44$4,300$98
Potassium Citrate Er38$4,182$110
Nitrofurantoin Mono-Macro96$3,600$38
Methenamine Hippurate30$3,274$109
Finasteride99$2,271$23
Tadalafil20$1,977$99
Solifenacin21$1,684$80
Ciprofloxacin217$1,347$6
Cefuroxime64$1,142$18
Testosterone12$1,134$94
Oxybutynin Chloride Er14$576$41
Bicalutamide25$523$21
Sulfamethoxazole-Trimethoprim47$457$10
Terazosin11$256$23
Tramadol47$138$3
Meloxicam11$137$12
Levofloxacin15$137$9
Zolpidem11$48$4
Ibuprofen16$32$2

2022: 28 drugs

Part D drugs prescribed in 2022
Myrbetriq87$52,526$604
Dutasteride224$16,584$74
Tamsulosin801$14,814$18
Toviaz18$10,273$571
Alfuzosin Hcl Er195$7,873$40
Nitrofurantoin Mono-Macro102$5,311$52
Bethanechol Chloride94$4,801$51
Potassium Citrate Er30$2,490$83
Betamethasone Dipropionate12$2,270$189
Fesoterodine Fumarate Er16$2,236$140
Cefuroxime98$2,083$21
Finasteride110$1,917$17
Testosterone11$1,908$173
Solifenacin20$1,204$60
Ciprofloxacin216$919$4
Bicalutamide28$810$29
Oxybutynin Chloride Er18$621$35
Rosuvastatin21$456$22
Sulfamethoxazole-Trimethoprim58$348$6
Pentoxifylline17$317$19
Terazosin12$190$16
Tramadol52$139$3
Metformin11$103$9
Hydrocodone-Acetaminophen12$59$5
Pravastatin11$58$5
Ibuprofen20$44$2
Zolpidem13$39$3
Meloxicam13$30$2

2021: 31 drugs

Part D drugs prescribed in 2021
Xtandi14$173,372$12,384
Myrbetriq108$64,285$595
Toviaz21$16,569$789
Testosterone28$14,196$507
Dutasteride193$12,662$66
Tamsulosin780$12,530$16
Alfuzosin Hcl Er229$9,106$40
Tadalafil15$7,084$472
Nitrofurantoin Mono-Macro99$5,431$55
Bethanechol Chloride51$4,779$94
Finasteride155$4,074$26
Potassium Citrate Er38$3,171$83
Oxybutynin Chloride Er49$2,715$55
Solifenacin30$2,252$75
Cefuroxime71$1,482$21
Bicalutamide29$1,314$45
Ciprofloxacin281$1,094$4
Pentoxifylline22$556$25
Testosterone Cypionate13$482$37
Sulfamethoxazole-Trimethoprim43$267$6
Hydrocodone-Acetaminophen51$245$5
Oxybutynin Chloride18$225$13
Amlodipine Besylate11$171$16
Allopurinol16$165$10
Tramadol52$154$3
Terazosin12$137$11
Phenazopyridine13$126$10
Alprazolam12$89$7
Ibuprofen50$76$2
Zolpidem15$52$3
Lorazepam23$22$1

2020: 32 drugs

Part D drugs prescribed in 2020
Xtandi34$371,883$10,938
Myrbetriq167$93,121$558
Lupron Depot32$79,037$2,470
Toviaz48$32,792$683
Testosterone24$24,341$1,014
Dutasteride254$21,266$84
Tamsulosin981$17,663$18
Alfuzosin Hcl Er329$13,084$40
Tadalafil20$12,947$647
Nitrofurantoin Mono-Macro146$7,081$49
Bethanechol Chloride51$5,602$110
Finasteride221$5,187$23
Oxybutynin Chloride Er76$4,176$55
Silodosin21$3,582$171
Potassium Citrate Er27$3,199$118
Bicalutamide46$2,806$61
Solifenacin20$2,328$116
Betamethasone Dipropionate13$1,820$140
Ciprofloxacin392$1,772$5
Nystatin-Triamcinolone24$1,654$69
Cefuroxime60$1,358$23
Testosterone Cypionate23$1,118$49
Oxybutynin Chloride22$684$31
Tramadol77$337$4
Allopurinol27$331$12
Sulfamethoxazole-Trimethoprim50$264$5
Amlodipine Besylate19$93$5
Hydrocodone-Acetaminophen30$87$3
Ibuprofen21$49$2
Alprazolam11$39$4
Hydrochlorothiazide14$30$2
Lorazepam18$15$1

2019: 35 drugs

Part D drugs prescribed in 2019
Xtandi30$300,595$10,020
Myrbetriq169$89,201$528
Lupron Depot21$51,811$2,467
Androgel11$46,481$4,226
Toviaz72$41,035$570
Tamsulosin883$17,226$20
Dutasteride231$16,493$71
Alfuzosin Hcl Er313$11,604$37
Vesicare20$9,751$488
Testosterone21$7,615$363
Bethanechol Chloride62$7,095$114
Tadalafil21$6,431$306
Solifenacin22$5,925$269
Nitrofurantoin Mono-Macro137$5,835$43
Finasteride222$5,699$26
Potassium Citrate Er32$4,508$141
Silodosin26$4,043$156
Oxybutynin Chloride Er52$3,401$65
Ciprofloxacin444$3,038$7
Bicalutamide56$2,319$41
Nystatin-Triamcinolone25$1,898$76
Testosterone Cypionate38$1,608$42
Oxybutynin Chloride29$1,096$38
Cefuroxime47$804$17
Pentoxifylline19$767$40
Doxazosin Mesylate17$666$39
Tramadol100$311$3
Sulfamethoxazole-Trimethoprim48$282$6
Terazosin14$201$14
Allopurinol16$178$11
Alprazolam12$74$6
Hydrocodone-Acetaminophen20$66$3
Meloxicam23$48$2
Zolpidem13$47$4
Lorazepam21$23$1

2018: 28 drugs

Part D drugs prescribed in 2018
Myrbetriq78$46,029$590
Toviaz72$29,766$413
Lupron Depot12$24,360$2,030
Vesicare64$18,479$289
Rapaflo30$16,961$565
Tamsulosin672$13,988$21
Alfuzosin Hcl Er238$8,633$36
Dutasteride105$6,396$61
Cialis18$6,389$355
Testosterone14$4,825$345
Finasteride212$4,649$22
Nitrofurantoin Mono-Macro97$4,034$42
Bethanechol Chloride46$3,443$75
Potassium Citrate Er29$2,498$86
Ciprofloxacin333$2,159$6
Testosterone Cypionate52$2,067$40
Bicalutamide49$1,772$36
Cefuroxime53$1,198$23
Oxybutynin Chloride24$716$30
Oxybutynin Chloride Er16$692$43
Terazosin11$238$22
Sulfamethoxazole-Trimethoprim34$181$5
Levofloxacin16$180$11
Tramadol62$165$3
Azithromycin18$142$8
Alprazolam11$68$6
Zolpidem13$36$3
Lorazepam19$20$1

2017: 28 drugs

Part D drugs prescribed in 2017
Myrbetriq72$34,483$479
Rapaflo26$11,500$442
Tamsulosin491$10,629$22
Toviaz30$9,900$330
Cialis23$9,606$418
Vesicare26$9,455$364
Androgel12$6,776$565
Alfuzosin Hcl Er224$6,179$28
Dutasteride57$4,822$85
Nitrofurantoin Mono-Macro62$3,116$50
Finasteride159$3,102$20
Bethanechol Chloride39$2,141$55
Testosterone Cypionate51$2,053$40
Valacyclovir17$1,620$95
Potassium Citrate Er18$1,293$72
Ciprofloxacin194$1,229$6
Bicalutamide32$1,199$37
Cefuroxime27$639$24
Oxybutynin Chloride15$575$38
Doxazosin Mesylate11$545$50
Allopurinol15$328$22
Levofloxacin37$275$7
Terazosin14$274$20
Tramadol71$238$3
Sulfamethoxazole-Trimethoprim26$161$6
Azithromycin16$138$9
Escitalopram12$64$5
Hydrochlorothiazide11$29$3

2016: 28 drugs

Part D drugs prescribed in 2016
Rapaflo49$17,253$352
Toviaz49$14,423$294
Tamsulosin465$11,009$24
Myrbetriq24$10,737$447
Androgel17$8,577$505
Vesicare26$7,532$290
Avodart21$7,235$345
Cialis21$6,304$300
Dutasteride58$5,965$103
Alfuzosin Hcl Er163$4,213$26
Bethanechol Chloride69$3,949$57
Nitrofurantoin Mono-Macro60$2,569$43
Finasteride152$2,568$17
Nystatin-Triamcinolone11$1,901$173
Levofloxacin241$1,891$8
Potassium Citrate Er19$1,029$54
Doxazosin Mesylate21$969$46
Cefuroxime24$793$33
Ciprofloxacin81$671$8
Bicalutamide13$509$39
Allopurinol19$405$21
Terazosin15$327$22
Hydrocodone-Acetaminophen21$201$10
Tramadol71$197$3
Sulfamethoxazole-Trimethoprim23$121$5
Escitalopram12$60$5
Hydrochlorothiazide15$39$3
Meloxicam11$26$2

2015: 28 drugs

Part D drugs prescribed in 2015
Avodart135$27,919$207
Toviaz79$20,639$261
Rapaflo57$13,142$231
Tamsulosin399$12,969$33
Androgel19$10,276$541
Vesicare44$10,090$229
Jalyn26$6,932$267
Myrbetriq12$5,268$439
Bethanechol Chloride59$3,442$58
Alfuzosin Hcl Er171$3,222$19
Cialis13$3,113$239
Nystatin-Triamcinolone13$2,345$180
Finasteride159$2,047$13
Phenazopyridine30$2,010$67
Nitrofurantoin Mono-Macro43$1,739$40
Ciprofloxacin271$1,629$6
Cefuroxime39$1,466$38
Doxazosin Mesylate20$1,047$52
Bicalutamide25$783$31
Allopurinol18$284$16
Terazosin23$283$12
Oxybutynin Chloride11$279$25
Sulfamethoxazole-Trimethoprim30$231$8
Tramadol42$137$3
Escitalopram12$76$6
Lorazepam20$69$3
Sertraline11$68$6
Meloxicam20$53$3

2014: 27 drugs

Part D drugs prescribed in 2014
Avodart147$28,492$194
Vesicare79$18,157$230
Androgel43$17,829$415
Jalyn70$15,383$220
Toviaz68$13,863$204
Rapaflo62$11,465$185
Tamsulosin349$7,463$21
Myrbetriq19$6,669$351
Axiron12$5,688$474
Nystatin-Triamcinolone24$4,379$182
Alfuzosin Hcl Er130$3,561$27
Nitrofurantoin Mono-Macro53$2,989$56
Bicalutamide35$1,639$47
Quetiapine12$1,636$136
Finasteride76$1,593$21
Ciprofloxacin275$1,586$6
Doxazosin Mesylate37$1,564$42
Oxybutynin Chloride37$1,289$35
Bethanechol Chloride30$1,264$42
Cefuroxime19$641$34
Hydrocodone-Acetaminophen43$288$7
Sulfamethoxazole-Trimethoprim28$235$8
Terazosin25$198$8
Phenazopyridine14$174$12
Sertraline16$114$7
Lorazepam20$57$3
Ibuprofen11$55$5

2013: 32 drugs

Part D drugs prescribed in 2013
Vesicare118$29,034$246
Avodart137$25,222$184
Androgel65$23,458$361
Jalyn85$16,306$192
Testim19$8,832$465
Rapaflo42$8,245$196
Elmiron12$8,118$676
Tamsulosin327$7,432$23
Toviaz29$5,058$174
Alfuzosin104$4,494$43
Fortesta12$4,151$346
Nitrofurantoin Mono-Macro52$3,476$67
Nystatin-Triamcinolone19$2,922$154
Quetiapine12$2,350$196
Finasteride72$2,304$32
Ciprofloxacin290$1,827$6
Bicalutamide32$1,686$53
Bethanechol Chloride25$1,169$47
Atorvastatin11$770$70
Doxazosin Mesylate30$655$22
Hydrocodone-Acetaminophen65$512$8
Oxybutynin Chloride17$484$28
Cefuroxime26$356$14
Terazosin32$303$9
Sulfamethoxazole-Trimethoprim35$254$7
Phenazopyridine31$220$7
Levofloxacin23$158$7
Sertraline16$130$8
Meloxicam15$103$7
Atenolol12$95$8
Lorazepam23$73$3
Zolpidem14$49$4

Money from drug and device companies

$222 in 2025

Industry payments by year
202534None$222
202445None$115
202355None$95
202255None$184
202156None$175
202011None$22
2019511None$479

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
TeleflexUrolift$191
2 payments
  • Meals for Urolift · 2025-12-03 · $155
  • Meals for Urolift · 2025-07-08 · $36
ColoplastColoplast Tfl Drive$16
1 payment
  • Meals for Coloplast Tfl Drive · 2025-09-18 · $16
Sumitomo Pharma AmericaOrgovyx$14
1 payment
  • Meals for Orgovyx · 2025-02-04 · $14
See all 4 published payments
Every published payment
TeleflexMeals · 2025-12-03Urolift$155
ColoplastMeals · 2025-09-18Coloplast Tfl Drive$16
TeleflexMeals · 2025-07-08Urolift$36
Sumitomo Pharma AmericaMeals · 2025-02-04Orgovyx$14
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $115

Payments by company in 2024
Sumitomo Pharma AmericaGemtesa$50
2 payments
  • Meals for Gemtesa · 2024-08-27 · $30
  • Meals for Gemtesa · 2024-02-27 · $19
PROCEPT BioRoboticsAquabeam System$27
1 payment
  • Meals for Aquabeam System · 2024-10-15 · $27
AbbvieLupron Depot$23
1 payment
  • Meals for Lupron Depot · 2024-06-13 · $23
TolmarEligard$16
1 payment
  • Meals for Eligard · 2024-09-17 · $16

2023: $95

Payments by company in 2023
UroGen PharmaJelmyto$28
1 payment
  • Meals for Jelmyto · 2023-06-13 · $28
Sumitomo Pharma AmericaOrgovyx$24
1 payment
  • Meals for Orgovyx · 2023-08-29 · $24
AbbVieLupron Depot$16
1 payment
  • Meals for Lupron Depot · 2023-09-11 · $16
Myriad Genetic LaboratoriesNone$14
1 payment
  • Meals · 2023-12-04 · $14
Astellas Pharma USMyrbetriq$13
1 payment
  • Meals for Myrbetriq · 2023-02-28 · $13

2022: $184

Payments by company in 2022
Astellas Pharma USNone$90
1 payment
  • Education · 2022-03-18 · $90
TeleflexUrolift$40
1 payment
  • Meals for Urolift · 2022-10-20 · $40
PfizerXtandi$23
1 payment
  • Meals for Xtandi · 2022-10-03 · $23
AxonicsAxonics$17
1 payment
  • Meals for Axonics · 2022-03-15 · $17
Endo PharmaceuticalsXiaflex$14
1 payment
  • Meals for Xiaflex · 2022-07-12 · $14

2021: $175

Payments by company in 2021
TeleflexUrolift System$57
1 payment
  • Meals for Urolift System · 2021-04-26 · $57
PfizerXtandi$52
2 payments
  • Meals for Xtandi · 2021-05-27 · $23
  • Meals for Xtandi · 2021-02-09 · $29
Acerus PharmaceuticalsNatesto$25
1 payment
  • Meals for Natesto · 2021-12-03 · $25
Myovant SciencesOrgovyx$24
1 payment
  • Education for Orgovyx · 2021-03-01 · $24
MedtronicInterstim$17
1 payment
  • Meals for Interstim · 2021-10-05 · $17

2020: $22

Payments by company in 2020
Baxter HealthcareTisseel$22
1 payment
  • Meals for Tisseel · 2020-09-17 · $22

2019: $479

Payments by company in 2019
Astellas Pharma USXtandi$167
7 payments
  • Meals for Xtandi · 2019-12-13 · $12
  • Meals for Xtandi · 2019-11-15 · $11
  • Meals for Xtandi · 2019-10-11 · $11
  • Education for Xtandi · 2019-08-09 · $8
  • Meals for Xtandi · 2019-07-12 · $11
  • Meals for Myrbetriq · 2019-02-22 · $15
  • Education · 2019-01-04 · $100
Teva Pharmaceuticals USAAjovy$130
1 payment
  • Meals for Ajovy · 2019-04-17 · $130
ColoplastAltis$115
1 payment
  • Travel for Altis · 2019-01-21 · $115
ConmedAirseal$55
1 payment
  • Meals for Airseal · 2019-01-22 · $55
PfizerXtandi$13
1 payment
  • Meals for Xtandi · 2019-03-26 · $13

Professional record

NPI
1922116698
Licence
CA A35822California A35822: Current · expires 2028-01-31
Gender
Male
More record details
Sole proprietor
Yes
Medicaid ID
CA 00A35822
Taxonomy
Federal specialty code 174400000X (174400000X)
Mailing address
1360 W 6th St Ste 160, San Pedro, CA, 90732
NPI first listed
2006-08-25
NPI last updated
2008-11-21

This is when the NPI record was last certified, not a medical board exam.